Zobrazeno 1 - 10
of 213
pro vyhledávání: '"M. Narabayashi"'
Autor:
N. Kishi, Y. Matsuo, T. Shintani, M. Ogura, T. Mitsuyoshi, N. Araki, K. Fujii, S. Okumura, K. Nakamatsu, T. Kishi, T. Atsuta, T. Sakamoto, S. Otsu, T. Katagiri, M. Narabayashi, S. Fujishiro, Y. Iizuka, H. Ozasa, T. Mizowaki
Publikováno v:
Radiotherapy and Oncology. 170:S1077-S1078
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e56538bd58e437fec4ea99a955f37082
https://doi.org/10.1016/s0167-8140(22)03243-1
https://doi.org/10.1016/s0167-8140(22)03243-1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Iki Adachi, Tomoko Ohtsu, Y. Omuro, M. Narabayashi, Tetsuo Taguchi, Noriyuki Katsumata, H. Fujii, K. Itoh, D. F. Ying, Tadahiko Igarashi, Masahiko Ando, Yasutsuna Sasaki, Takashi Watanabe, H. Wakita, Y. Tokue
Publikováno v:
British Journal of Cancer
To determine the maximum-tolerated doses (MTDs), the dose-limiting toxicities (DLTs) and the recommended doses for further trials of docetaxel in combination with a 5-day continuous infusion of 5-fluorouracil (5-FU) in advanced or recurrent breast ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf30ee42377339cd31a7d232a2674632
https://doi.org/10.1038/bjc.1998.321
https://doi.org/10.1038/bjc.1998.321
Autor:
H Aoyama, M. Narabayashi, Shigemitsu Takashima, Noboru Horikoshi, Tetsuo Taguchi, Iki Adachi, Takashi Watanabe
Publikováno v:
British Journal of Cancer
A late phase II clinical trial of RP56976 (docetaxel), derived from Taxus baccata was performed to evaluate anti-tumour activity, time to progression and clinical toxicity in patients with advanced or recurrent breast cancer. The patients, between 15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed8d5c532addf26ece13450a4b613c04
https://doi.org/10.1038/bjc.1996.37
https://doi.org/10.1038/bjc.1996.37
Autor:
M, Narabayashi, K, Takeyama, T, Fukutomi, Y, Tokuda, T, Tajima, A, Okumura, T, Chou, M, Sano, H, Makino, T, Igarashi, Y, Sasaki, S, Imoto, M, Ogura, Y, Morishima, H, Murai, S, Okamoto, T, Ikeda, M, Kasai, T, Yokozawa, K, Tobinai
Publikováno v:
Japanese journal of clinical oncology. 29(6)
The optimum dose of granulocyte colony-stimulating factor (G-CSF) for peripheral blood stem cell (PBSC) mobilization after disease-oriented, conventional-dose chemotherapy remains unknown.A multicenter dose-finding study of glycosylated G-CSF (lenogr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::43167f7f6fe5250f7aecad5c35893d11
https://pubmed.ncbi.nlm.nih.gov/10418556
https://pubmed.ncbi.nlm.nih.gov/10418556
Autor:
Y, Kobayashi, M, Nakata, N, Sato, Y, Kamiya, A, Maeda, K, Togitani, N, Kawahigashi, T, Murayama, T, Yokozawa, K, Takeyama, M, Narabayashi, T, Takenaka, K, Tobinai
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 39(6)
A 53-year-old female case of cytogenetically relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation (BMT) who achieved remission by withdrawal of immunosuppressant is reported. On day 690 of this presentation she is well and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dade83d3ce9c970a7f0f1c9e832f83a7
https://pubmed.ncbi.nlm.nih.gov/9695678
https://pubmed.ncbi.nlm.nih.gov/9695678
Autor:
K, Tobinai, Y, Kobayashi, M, Narabayashi, M, Ogura, Y, Kagami, Y, Morishima, T, Ohtsu, T, Igarashi, Y, Sasaki, T, Kinoshita, T, Murate
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 9(5)
In clinical trials in the USA, IDEC-C2B8 (a mouse-human chimeric anti-CD20 monoclonal antibody) has demonstrated high response rates with only mild toxic effects in relapsed B-cell lymphoma at a dose of four weekly 375 mg/m2 infusions. The aim of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::75c7f50117cb50143d861e27f0fb25c2
https://pubmed.ncbi.nlm.nih.gov/9653494
https://pubmed.ncbi.nlm.nih.gov/9653494
Autor:
M, Andoh, M, Narabayashi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 25(2)
A 29-year-old Japanese man was admitted to our hospital because of further examination of his mediastinal abnormal shadow on the chest roentogenogram detected in an annual medical examination. He was asymptomatic and had no abnormal findings on physi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0df9d9a69ea1c9bbbc09316e2d2e28e6
https://pubmed.ncbi.nlm.nih.gov/9474935
https://pubmed.ncbi.nlm.nih.gov/9474935
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.